FDA.reportPublic FDA data

Application 020951

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TAGAMET HB 200CIMETIDINESUSPENSION;ORAL200MG/20MLNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
21299ORIG2000-05-18
26287ORIG1999-07-09
13809ORIG1999-07-09